Intco Medical Technology Co., Ltd. (SHE: 300677)

Intco Medical Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	11,529	7,222	5,033	5,003	5,009	614.28
Short-Term Investments	-	723.21	1,613	-	-	-
Trading Asset Securities	6,855	5,236	1,624	3,274	1,381	257.9
Cash & Short-Term Investments	18,384	13,181	8,270	8,277	6,390	872.17
Cash Growth	78.42%	59.39%	-0.09%	29.52%	632.70%	1.66%
Accounts Receivable	1,432	937.18	555.36	775.15	516.88	331.83
Other Receivables	96.1	41.89	80.93	30.6	64.14	65.86
Receivables	1,529	979.08	636.29	805.75	581.03	397.69
Inventory	1,263	1,150	1,004	1,079	847.45	233.26
Other Current Assets	451.58	292.93	325.23	600.95	690.81	41.09
Total Current Assets	21,627	15,603	10,235	10,763	8,510	1,544
Property, Plant & Equipment	9,517	9,246	8,911	8,262	3,572	1,108
Long-Term Investments	1,191	970.38	884.94	473.89	15.67	13.5
Other Intangible Assets	775.62	566.84	583.48	629.91	349.48	195.34
Long-Term Deferred Tax Assets	65.17	64.09	88.31	77.23	158.77	8.24
Long-Term Deferred Charges	0.53	1.84	1.76	2.9	14.91	0.5
Other Long-Term Assets	600.74	627.32	774.31	415.84	314.2	122.07
Total Assets	33,777	27,079	21,479	20,625	12,935	2,992
Accounts Payable	752.45	921.6	946.36	1,238	856.09	297.78
Accrued Expenses	100.58	174.47	201.53	194	124.49	41.85
Short-Term Debt	13,111	7,034	1,494	50.48	22.18	462.82
Current Portion of Long-Term Debt	82.05	53.4	29.04	34.29	27.88	17.42
Current Portion of Leases	-	1.94	4.01	2.64	-	-
Current Income Taxes Payable	98.94	15.64	9.63	37.5	163.26	0.24
Current Unearned Revenue	327.39	293.6	300.89	414.16	917.4	23.48
Other Current Liabilities	181.07	123.67	169.43	113.07	116.79	24.12
Total Current Liabilities	14,654	8,618	3,155	2,084	2,228	867.71
Long-Term Debt	76.1	77.25	51.59	201.26	230.09	535.38
Long-Term Leases	-	-	1.78	3.38	-	-
Long-Term Unearned Revenue	155.92	123.99	128.53	201.02	68.14	58.71
Long-Term Deferred Tax Liabilities	1,869	1,965	2,093	2,012	965.72	28.42
Total Liabilities	16,825	10,785	5,429	4,501	3,492	1,490
Common Stock	647.9	656	659.55	549.58	352.22	198.3
Additional Paid-In Capital	1,130	1,287	1,310	1,509	1,586	638.34
Retained Earnings	15,032	14,396	14,072	13,855	7,481	617.84
Treasury Stock	-153.39	-320.55	-253.81	-27.76	-72.21	-22.84
Comprehensive Income & Other	17.59	10.63	18.79	-15.22	-2.45	45.68
Total Common Equity	16,673	16,029	15,806	15,871	9,344	1,477
Minority Interest	278.31	265.99	242.93	252.25	98.91	24.45
Shareholders' Equity	16,952	16,295	16,049	16,123	9,443	1,502
Total Liabilities & Equity	33,777	27,079	21,479	20,625	12,935	2,992
Total Debt	13,270	7,166	1,580	292.05	280.15	1,016
Net Cash (Debt)	5,114	6,015	6,689	7,985	6,110	-143.44
Net Cash Growth	2.32%	-10.08%	-16.22%	30.68%	-	-
Net Cash Per Share	7.81	9.11	10.10	11.82	9.86	-0.26
Filing Date Shares Outstanding	659.68	656	659.55	659.49	634	535.41
Total Common Shares Outstanding	659.68	656	659.55	659.49	634	535.41
Working Capital	6,974	6,985	7,080	8,679	6,282	676.5
Book Value Per Share	25.27	24.43	23.97	24.07	14.74	2.76
Tangible Book Value	15,898	15,462	15,223	15,241	8,994	1,282
Tangible Book Value Per Share	24.10	23.57	23.08	23.11	14.19	2.39
Land	-	11.72	11.52	10.55	-	-
Buildings	-	4,057	3,480	2,400	883.6	438.37
Machinery	-	5,613	4,986	4,247	2,305	826.55
Construction In Progress	-	1,509	1,705	2,326	863.41	195.95

Source: S&P Capital IQ. Standard template. Financial Sources.